In a meta-analysis by Lin, the risk of DKA was numerically more than three times higher in patients with atherosclerotic cardiovascular disease (ASCVD) than in those without, although this did not reach statistical significance.
← all excerpts
Sodium-Glucose Cotransporter-2 Inhibitors in Diabetes and Beyond: Mechanisms, Pleiotropic Benefits, and Clinical Use-Reviewing Protective Effects Exceeding Glycemic Control.
1
—
—